Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
This study aims to understand why Idiopathic Pulmonary Fibrosis (IPF), a lung disease that causes scarring, gets worse in some people faster than others. Researchers are looking for genetic and biological markers in your body that might predict how quickly your lung function will decline. The goal is to learn if and when patients might experience a rapid worsening of their IPF. You can join if you are 18 or older, have a diagnosis of IPF, and are being treated at the Simmons Center. People with other lung illnesses cannot participate. The study is currently unclear on its recruitment status.
- Study design
- This is an observational study planning to enroll 500 participants. It is not testing a specific drug or treatment.
- What's involved
- You will have an initial visit with blood draws, lung function tests, heart ultrasounds (echocardiograms), CT scans, and questionnaires. Follow-up visits will occur every 3-4 months for blood samples, and questionnaires will be completed every 6-8 months. If your lung function declines rapidly, a bronchoscopy (a procedure to look into your lungs) may be performed.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
At a glance
A primary outcome measure isn't published for this study.
Conditions
NCT00373841
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Michelle F MacPherson
Pittsburgh, Pennsylvaniastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Kevin F Gibson, MD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh - Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.